Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Dysbiosis in the intestinal microbiota of persons with inflammatory bowel disease (IBD) has been described, but there are still varied reports on changes in the abundance of Bifidobacterium and Lactobacillus organisms in patients with IBD. The aim of this investigation was to compare the compositions of mucosa-associated and fecal bacteria in patients with IBD and in healthy controls (HCs). Fecal and biopsy samples from 21 HCs, 21 and 15 Crohn's disease (CD) patients, and 34 and 29 ulcerative colitis (UC) patients, respectively, were analyzed by quantitative real-time PCR targeting the 16S rRNA gene. The bacterial numbers were transformed into relative percentages for statistical analysis. The proportions of bacteria were uniformly distributed along the colon regardless of the disease state. Bifidobacterium was significantly increased in the biopsy specimens of active UC patients compared to those in the HCs (4.6% versus 2.1%, P = 0.001), and the proportion of Bifidobacterium was significantly higher in the biopsy specimens than in the fecal samples in active CD patients (2.7% versus 2.0%, P = 0.012). The Lactobacillus group was significantly increased in the biopsy specimens of active CD patients compared to those in the HCs (3.4% versus 2.3%, P = 0.036). Compared to the HCs, Faecalibacterium prausnitzii was sharply decreased in both the fecal and biopsy specimens of the active CD patients (0.3% versus 14.0%, P < 0.0001 for fecal samples; 0.8% versus 11.4%, P < 0.0001 for biopsy specimens) and the active UC patients (4.3% versus 14.0%, P = 0.001 for fecal samples; 2.8% versus 11.4%, P < 0.0001 for biopsy specimens). In conclusion, Bifidobacterium and the Lactobacillus group were increased in active IBD patients and should be used more cautiously as probiotics during the active phase of IBD. Butyrate-producing bacteria might be important to gut homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with inflammatory bowel disease (IBD) have been associated with reduced bacterial diversity and a decline in butyrate-producing bacteria such as Faecalibacterium prausnitzii, indicating the importance of gut dysbiosis in IBD [138, 139].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [139]
In the citing paper
“mucosa-associated microbes preferentially regulate host homeostasis, as is evident in the induction of T-cell immune responses, as well as maintaining serotonin biosynthesis from dietary tryptophan in the mucosa.28, 29, 30, 31, 32, 33”
From Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder (2017) · cites this paper as [28]
Citations
Cites
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · cited 1×
“In our study, we found that the proportions of detected mucosa-associated bacteria in healthy gastrointestinal tracts were uniformly distributed along the colon, which was in accordance with the findings from a previous study (23, 24).”
ResultFrank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 2×
“leptum group was strikingly low in mucosa-associated microbiotas (40, 41).”
BackgroundSokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 1×
“One study suggested that Faecalibacterium prausnitzii prevents 2,4,6-trinitrobenzenesulfonic acid (TNBS)induced colitis (16).”
BackgroundDevelopment of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Mucosal flora in inflammatory bowel disease
Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening–Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,346
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
Cited by
Items 301–400 of 510
Jang, J., Jang, S.-Y., Ahn, S., Oh, J., Yeom, M., Ko, S., Park, J.-W., Kwon, S.-K., Kim, K., Lee, I., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052753 · Cited by 15
“It is noteworthy that similar increases in the gut abundance of Rikenellaceae , Alistipes , Tenericutes , and Eubacterium have been observed in human IBS patients [22–25], as well as increases in that of Lactobacillus and Bacilli in patients with IBD [26,27].”
ResultYan, B., Chen, X., Wang, Y., Yuan, M., Xian, J., Lu, D., Shao, Z., Qiu, M., Fu, T., & Zheng, X. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106414 · Cited by 19
Vetreno, R. P., Massey, V. L., & Crews, F. T. (2019) · Addiction Biology · doi:10.1111/adb.12869 · Cited by 14
The responses of the gut microbiota to MBL deficiency
Wu, M., Wang, F., Yang, H. J., Li, P., Yan, D., Yang, Y., Zhang, W., Ren, J., Zhang, Z., & Wang, M. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.03.008 · Cited by 16
Quantitative changes in selected bacteria in the stool during the treatment of Crohn's disease
Salamon, D., Gosiewski, T., Krawczyk, A., Sroka-Oleksiak, A., Duplaga, M., Fyderek, K., & Kowalska‐Duplaga, K. (2020) · Advances in Medical Sciences · doi:10.1016/j.advms.2020.06.003 · Cited by 16
“Some authors reported a decrease while others observed an increase in the numbers of these microorganisms in the course of CD [17,18,24].”
BackgroundYao, Y., Feng, Q., & Shen, J. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1850269 · Cited by 16
Fu, S., Lee, C., Hsieh, Y., Wu, P.-H., Lin, S., & Wang, H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.837019 · Cited by 19
An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?
Burman, S., Hoedt, E. C., Pottenger, S., Mohd-Najman, N.-S., Cuív, P. Ó., & Morrison, M. (2016) · Digestive Diseases · doi:10.1159/000443759 · Cited by 16
Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension
Yokoyama, K., Tsuchiya, N., Yamauchi, R., Miyayama, T., Uchida, Y., Shibata, K., Fukuda, H., Umeda, K., Takata, K., Tanaka, T., et al. (2020) · Internal Medicine · doi:10.2169/internalmedicine.4628-20 · Cited by 16
“However, it should be noted that in recent years, the levels of the Bifidobacterium genus have been reported to increase with both alcohol dependence and alcoholic liver cirrhosis (28-30).”
BackgroundWang, C., Qin, S., Shi, J., Zhu, J., Ju, X., Wang, W., & Yang, L. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.124097 · Cited by 16
Self-citationBarron, M. R., Sovacool, K. L., Close, L. A., Vendrov, K. C., Standke, A. K., Bergin, I. L., Schloss, P. D., & Young, V. B. (2022) · mBio · doi:10.1128/mbio.01904-22 · Cited by 16
“characterized by decreases in short chain fatty acid concentrations and altered bile acid 69 profiles (14-16).”
BackgroundLin, Z., Luo, W. T., Zhang, K., & Dai, S. (2023) · Gut and Liver · doi:10.5009/gnl230179 · Cited by 18
Molecular Manipulations and Intestinal Stem Cell-Derived Organoids in Inflammatory Bowel Disease
Boye, T. L., Steenholdt, C., Jensen, K. B., & Nielsen, O. H. (2022) · Stem Cells · doi:10.1093/stmcls/sxac014 · Cited by 14
Yoon, H., Yoon, Y.-S., Kim, M., Chung, M.-J., & Yum, D.-Y. (2014) · Toxicological Research · doi:10.5487/tr.2014.30.1.027 · Cited by 15
“Furthermore, the Lactobacillus casei Shirota suppressed IL-6 in IBD have been documented (18).”
BackgroundSong, M., Zhang, S., Zhang, Z., Guo, L., Liang, W., Li, C., & Wang, Z. (2024) · mSystems · doi:10.1128/msystems.00602-24 · Cited by 14
“Previous studies related to human intestinal diseases have proven that the bacteria-producing butyric acid, Clostridium , are important for intestinal homeostasis by producing butyric acid (47).”
BackgroundBosselaar, S., Dhelin, L., Dautel, E., Titécat, M., Duthoy, S., Stelmaszczyk, M., Delory, N., Violante, M. D. S., Machuron, F., Ait-Abderrahim, H., et al. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03368-4 · Cited by 15
“Several studies have shown decreased levels in bifidobacteria in IBD [8], while other increased abundance of bifidobacteria in UC (but not CD) compared to healthy controls [9–11].”
ResultPei, L.-Y., Ke, Y.-S., Zhao, H.-H., Liu, W., Wang, L., Jia, C., Shi, M.-N., Fu, Q.-H., Cui, J., & Li, S. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2750-y · Cited by 18
Mesnage, R., Calatayud, M., Duysburgh, C., Marzorati, M., & Antoniou, M. N. (2022) · Gut Microbiome · doi:10.1017/gmb.2022.5 · Cited by 15
Wardill, H. R., Choo, J. M., Dmochowska, N., Mavrangelos, C., Campaniello, M. A., Bowen, J. M., Rogers, G. B., & Hughes, P. A. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz011 · Cited by 13
Scarpellini, E., BASILICO, M., Rinninella, E., Carbone, F., Schol, J., RASETTI, C., Abenavoli, L., & SANTORI, P. (2021) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02910-7 · Cited by 18
Brown, H. N., Barber, T. M., Renshaw, D. W., Farnaud, S., Oduro‐Donkor, D., & Turner, M. C. (2023) · Obesity Reviews · doi:10.1111/obr.13600 · Cited by 13
“…as multiple sclerosis 41 Faecalibacterium prausnitzii (cid:129) Blocks NF-к B activation, thus inhibiting secretion of proinflammatory mediators 42,43 Enterococcus (cid:129) Associated with reduced hunger levels 13 influence neuroendocrine pathways that form the gut – brain axis and are…”
BackgroundMote, R. S., Carpenter, J. M., Dockman, R. L., Steinberger, A. J., Suen, G., Norberg, T., Harn, D. A., Wagner, J. J., & Filipov, N. M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197081 · Cited by 12
Intestinal FFA3 mediates obesogenic effects in mice on a Western diet
Lednovich, K., Nnyamah, C., Gough, S., Priyadarshini, M., Xu, K., Wicksteed, B. L., Mishra, S. P., Jain, S., Zapater, J. L., Yadav, H., et al. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00016.2022 · Cited by 12
Armstrong, H., Rahbari, M., Park, H., Sharon, D. M., Thiesen, A., Hotte, N., Sun, N., Syed, H., Abofayed, H., Wang, W., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01483-4 · Cited by 12
“Meanwhile, Lactobacillus species which have previously been associated with disease flare in IBD patients [40] were decreased following cART in the IL10−/− mice.”
BackgroundSelf-citationGao, K., Yu, X. L., Li, F., Huang, Y., Liu, J., Liu, S., Lu, L., Yang, R., & Wang, C. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1202768 · Cited by 12
“, 2012; Tremaroli and Bäckhed, 2012), and autoimmune system (Tremaroli and Bäckhed, 2012), as well as some infectious diseases (Wang et al., 2014).”
BackgroundQiu, B., Shen, Z., Yang, D., Qin, X., Ren, W., & Wang, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1273269 · Cited by 12
“Microbiome and metabolome examination of gastric biopsy tissues using histological techniques revealed a clear correlation between peptic ulcers and flora (Malik et al., 2023; Wang et al., 2023).”
BackgroundAnalyzing the Role of Gut Microbiota on the Onset of Autoimmune Diseases Using TNFΔARE Murine Model
Edwards, V., Smith, D., Meylan, F., Tiffany, L. J., Poncet, S., Wu, W. W., Phue, J., Santana-Quintero, L. V., Clouse, K. A., & Gabay, O. (2021) · Microorganisms · doi:10.3390/microorganisms10010073 · Cited by 14
“One interesting observation is the identification of specific bacterial genera that seem to play a role in the inflammatory process driven by TNF: Lactobacillus, Escherichia, Bacteroides and Parabacteroides, Actetanaerobacterium, Helicobacter, Clostridium and Lachnoclostridium, Eubacterium, Roseburia, Prevotella and O…”
BackgroundInfluentialFecal microbiota profile in patients with inflammatory bowel disease in Taiwan
Chang, T.-E., Luo, J., Yang, U., Huang, Y., Hou, M., & Lee, F. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000532 · Cited by 15
Hu, L., Lai, C., Li, Y. H., Sun, R., Yang, H., Liu, X., & Yu, P. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00848-x · Cited by 16
Wang, W., Zhang, Q., Zhao, J., Liu, T., Yao, J., Peng, X., Zhi, M., & Zhang, M. (2023) · Gastroenterology report · doi:10.1093/gastro/goae074 · Cited by 12
Self-citationBarnett, J. A., Josephson, J. K., Yuzbashian, E., Haskey, N., Hart, M. M., Soma, K. K., Verdugo, A., McComb, C. J., Bandy, M. L., Ghosh, S., et al. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.180437 · Cited by 13
Rob, F., Schierová, D., Stehlíková, Z., Kreisinger, J., Roubalová, R., Coufal, Š., Mihula, M., Jackova, Z., Kverka, M., Thon, T., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277576 · Cited by 12
“Although we did not find lactobacilli to be differentially abundant between HC and patients with IBD in our cohort, lactobacilli have been previously reported to be increased in patients with both CD and UC [49,50].”
BackgroundWidjaja, F., & Rietjens, I. M. C. M. (2023) · Biomedicines · doi:10.3390/biomedicines11102658 · Cited by 13
Lactoferrin deficiency during lactation increases the risk of depressive-like behavior in adult mice
Wang, W., Cheng, Z., Wang, X., An, Q., Huang, K., Dai, Y., Meng, Q., & Zhang, Y. (2023) · BMC Biology · doi:10.1186/s12915-023-01748-2 · Cited by 16
“However, a higher abundance of Bifidobacterium has been associated with IBD, indicating that specific strains have inflammatory potential [64].”
BackgroundSelf-citationThe role of the skin microbiota in the modulation of cutaneous inflammation—Lessons from the gut
Elias, A., McBain, A. J., & O’Neill, C. A. (2021) · Experimental Dermatology · doi:10.1111/exd.14420 · Cited by 10
Hernández-Rocha, C., Nayeri, S., Turpin, W., Steel, M., Borowski, K., Stempak, J. M., Conner, J., & Silverberg, M. S. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac001 · Cited by 11
Gabriel, P. T. S., O’Neil, T. R., Au, A., Tan, J. K., Pinget, G. V., Liu, Y., Fong, G., Ku, J., Glaros, E. N., Macia, L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084258 · Cited by 10
Shankar, S., Majumder, S., Mukherjee, S., Bhaduri, A., Kasturi, R., Ghosh, S., Iacucci, M., & Shivaji, U. N. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241258360 · Cited by 12
Microbiota-derived D-amino acids in intestinal homeostasis and inflammatory bowel disease
Miyamoto, K., & Sujino, T. (2026) · Inflammation and Regeneration · doi:10.1186/s41232-025-00403-3 · Cited by 10
“This figure was created with © BioRender.com Mediterraneibacter gnavus ( Ruminococcus gnavus ), Veil-lonella parvula , and Clostridium innocuum , are significantly expanded in IBD [26, 27, 32, 34, 41].”
Nutrition and the gut microbiome: a symbiotic dialogue influencing health and disease
Ray, S., & Shankaran, P. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1761992 · Cited by 16
Adamkova, P., Hradická, P., Gancarčíková, S., Kassayová, M., Ambro, Ľ., Bertková, I., Marônek, M., Iannaccone, S. F., & Demečková, V. (2021) · Pathogens · doi:10.3390/pathogens10020152 · Cited by 9
“The increased levels of lactobacilli were also observed in active IBD patients, while the population of butyric acid-producing bacteria decreased to some extent [50].”
BackgroundRenardy, M., Prokopienko, A. J., Maxwell, J. R., Flusberg, D. A., Makaryan, S., Selimkhanov, J., Vakilynejad, M., Subramanian, K., & Wille, L. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2952 · Cited by 10
“Reductions in microbes that can produce butyrate are associated with inflammatory bowel disease.(19,20) Thus, microbial consortia may be excellent conduits for delivering sustained levels of butyrate and other SCFAs to the diseased gut.”
BackgroundShi, A., Dong, L., Wu, Y., Liu, X., Li, W., Wang, J., Ji, X., Lv, H., Zhang, Y., & Wang, S. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105690 · Cited by 9
Ota, S., Sakuraba, H., Hiraga, H., Yoshida, S., Satake, M., Akemoto, Y., Tanaka, N., Watanabe, R., Maeda, T., Murai, Y., et al. (2020) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2020.100811 · Cited by 12
Gut microbiome status of urban and rural Filipino adults in relation to diet and metabolic disorders
Watanabe, M., Sianoya, A. C., Mishima, R., Therdtatha, P., Rodriguez, A., Ramos, D. C., Lee, Y. K., Dalmacio, L. M. M., & Nakayama, J. (2021) · FEMS Microbiology Letters · doi:10.1093/femsle/fnab149 · Cited by 13
Dynamic human gut microbiome and immune shifts during an immersive psychosocial intervention program
Zhou, X., Ganz, A. B., Rayner, A., Cheng, T. Y., Oba, H., Rolnik, B. M., Lancaster, S. M., Lu, X., Li, Y., Johnson, J. S., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.12.027 · Cited by 13
“…(Chen et al., 2023; Lee et al., 2021; Steenbergen et al., 2015; Venkataraman et al., 2021), our analysis and prior studies suggest that Bifidobacterium’s role in psychiatric disorders may be more complex than previously thought (Chung et al., 2019; Knudsen et al., 2021; Wang et al., 2014).”
Propionate suppresses colitis-associated colorectal cancer in mice by Or51e2
Kim, J. S., Jeong, M.-Y., Yoon, Y. E., Kim, Y., Lee, I., Choi, J., Lee, H. L., Shin, M., Hong, S., Chi, S., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118268 · Cited by 9
Jeong, S. H., Jung, J., Park, Y., Lee, S. J., & Lee, S. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118910 · Cited by 10
Liu, Z., Nie, J., Li, Y., Huang, M., Chen, Z., Yu, S., Zheng, J., Tan, Y., & Chen, S. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00542-8 · Cited by 11
Cicchinelli, S., Gemma, S., Pignataro, G., Piccioni, A., Ojetti, V., Gasbarrini, A., Franceschi, F., & Candelli, M. (2024) · Pharmaceuticals · doi:10.3390/ph17040490 · Cited by 9
Nenciarini, S., Rivero, D., Ciccione, A., Amoriello, R., Cerasuolo, B., Pallecchi, M., Bartolucci, G., Ballerini, C., & Cavalieri, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1399842 · Cited by 10
Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes?
Pellicano, C., Leodori, G., Innocenti, G. P., Gigante, A., & Rosato, E. (2019) · Nutrients · doi:10.3390/nu11112629 · Cited by 9
“, Bacteroides, Eubacterium, Faecalibacterium and Ruminococcus) [87,89].”
Zhao, J., Li, G., Lü, W., Huang, S., & Zhang, Z. (2019) · Microbial Ecology · doi:10.1007/s00248-019-01462-z · Cited by 8
“However, in a clinical study, an increased proportion of Lactobacillus and Bifidobacterium was also observed in patients with irritable bowel disease [63].”
BackgroundSelf-citationKaczmarczyk, O., Dąbek, A., Woźniakiewicz, M., Paśko, P., Piątek-Guziewicz, A., & Zwolinska-Wcislo, M. M. (2022) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16254 · Cited by 8
Markelova, M., Senina, A. M., Khusnutdinova, D. R., Siniagina, M., Kupriyanova, E., Shakirova, G., Odintsova, A. K., Abdulkhakov, R., Kolesnikova, I. V., Shagaleeva, O. Y., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097998 · Cited by 10
Gut microbiome in the Graves’ disease: Comparison before and after anti-thyroid drug treatment
Jeong, C., Baek, H.-S., Bae, J., Hwang, N., Ha, J., Cho, Y., & Lim, D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300678 · Cited by 11
Andriamihaja, M., & Blachier, F. (2024) · Exploration of Medicine · doi:10.37349/emed.2024.00220 · Cited by 7
Bajaj, A., Markandey, M., Samal, A., Goswami, S., Vuyyuru, S. K., Mohta, S., Kante, B., Kumar, P., Makharia, G., Kedia, S., et al. (2024) · Gut Pathogens · doi:10.1186/s13099-024-00654-4 · Cited by 9
“While both an increase of Bifidobacteria and Lactobacilli [57], and an increased production of primary BAs [47], have been associated with IBD incidence, the increased DCA production is contrary to previous observations.”
ResultChulkina, M., Tran, H. T. D., Uribe, G., McAninch, S. B., McAninch, C., Seideneck, A. M., He, B., Lanza, M. R., Khanipov, K., Golovko, G., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115553 · Cited by 7
“75 Whether dysbiosis is among the primary or secondary causes of inflammation in IBD remains debatable.”
A newborn derived monoclonal IgM antibody selectively modulates microbial metabolism in the gut
He, Z., Gong, S., Mu, F., Gu, Q., Kundu, P., Gao, Y., Lo‐Man, R., & Draheim, M. (2025) · Nature Communications · doi:10.1038/s41467-025-63585-x · Cited by 7
Thomas, S., Mercogliano, G., & Prendergast, G. C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276910 · Cited by 8
“Acinetobacter [21], Bifidobacterium [22], Clostridiaceae [23], Achromobacter [24], Burkholderia [25], Sutterella [26], Rhodococcus [27] and Stenotrophomonas [28] are also observed in the microbiome of UC in humans and animal models of the disease.”
BackgroundThe Anti-Inflammatory Effect of a Probiotic Cocktail in Human Feces Induced-Mouse Model
Salimi, A., Sepehr, A., Hejazifar, N., Talebi, M., Rohani, M., & Pourshafie, M. R. (2023) · Inflammation · doi:10.1007/s10753-023-01870-x · Cited by 9
“Obvious differences in the population of the gut microbiota between healthy and IBD patients and between inflammatory and nonin-flammatory gut segments have been identified [11–14].”
BackgroundKohil, A., Abdalla, W., Ibrahim, W. N., Al-Harbi, K. M., Al-Haidose, A., Al‐Asmakh, M., & Abdallah, A. M. (2023) · Medicina · doi:10.3390/medicina59091629 · Cited by 7
“There are only limited data on the role of the skin microbiota in rheumatoid autoimmune disorders such as SLE, and further studies are warranted to identify and elucidate the function of specific skin microbial species in the cutaneous manifestations of patients with rheumatoid disorders.”
BackgroundInfluentialIntestinal FFA2 promotes obesity by altering food intake in Western diet-fed mice
Lednovich, K., Gough, S., Priyadarshini, M., Pandya, N., Nnyamah, C., Xu, K., Wicksteed, B. L., Mishra, S. P., Jain, S., Zapater, J. L., et al. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0184 · Cited by 14
“Consistent with literature reporting reduced SCFA levels in a state of gut dysbiosis (Wang et al. 2014, Agus et al. 2016), we observed reduced levels of acetate, propionate ( P < 0.05) and butyrate ( P < 0.01) in both WD-fed mouse groups, with no differences between the Vil-FFA2 and FFA2 fl/fl…”
InfluentialDubinkina, V. B., Tyakht, A., Ilina, E. N., Ischenko, D. S., Kovarsky, B. A., Yarygin, K. S., Pavlenko, A. V., Popenko, A., Alexeev, D. G., Taraskina, A. E., et al. (2015) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20156106742 · Cited by 8
Zhai, J., Fu, R., Luo, S., Liu, X., Xie, Y., Cao, K., Ge, W., & Chen, Y. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151584 · Cited by 7
Decreased mucosal adhesion of Lactobacillus species in patients with inflammatory bowel disease.
Najafi, S., Sotoodehnejadnematalahi, F., Amiri, M. M., Pourshafie, M. R., & Rohani, M. (2022) · PubMed Central · doi:10.22088/cjim.13.4.71 · Cited by 10
“Moreover, they observed no difference between patients with the controlled disease and healthy ones (35).”
BackgroundCai, X., Zhou, N., Zou, Q., Peng, Y., Xu, L., Feng, L., & Liu, X. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02999-3 · Cited by 8
“Commonly, the decreased taxa are mainly short-chain fatty acid producers such as Faecalibacterium prausnitzii, Lactobacillus, Erysipelotrichaceae, and Bifidobacteriaceae [14, 15], while the increased taxa are mainly proinflammatory bacteria such as Fusobacterium and Escherichia members [16].”
BackgroundZhao, X., Xu, J., Wu, D., Chen, N., & Liu, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13030708 · Cited by 7
Tahmasebi, A., Beheshti, R., Mahmoudi, M., Jalilzadeh, M., & Salehi‐Pourmehr, H. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2025.108077 · Cited by 8
Seong, H. J., Park, Y. M., Kim, B. S., Yoo, H. J., Kim, T., Yoon, S. M., Kim, J., Lee, S., Lee, Y. K., Lee, D., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00714-w · Cited by 6
Clayton, C. A., Porter, I., Deng, B., McCallum, G., Srinivas, A., Sie, C., He, J., Pei, A., Tertigas, D., Pepin, D. M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102517 · Cited by 7
Wang, D., Jia, H., Du, Y., & Liu, Y. (2022) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13703 · Cited by 6
Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis
Kitae, H., Takagi, T., Naito, Y., Inoüe, R., Azuma, Y., Torii, T., Mizushima, K., Doi, T., Inoue, K., Dohi, O., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10051044 · Cited by 6
“A previous study of the gut microbiota in patients with active UC showed that Bifidobacterium and Lactobacillus increased, and Faecalibacterium decreased in colon biopsy specimens [16].”
BackgroundResultKhanna, K., Eslavath, M. R., Ganju, L., Mishra, K. P., Singh, S. B., & Kumar, B. (2021) · Journal of Proteins and Proteomics · doi:10.1007/s42485-021-00062-1 · Cited by 6
Taguer, M., Darbinian, E., Wark, K., Ter-Cheam, A., Stephens, D. A., & Maurice, C. F. (2021) · mSystems · doi:10.1128/msystems.00507-21 · Cited by 8
“The increased abundance and activity of Bifidobacterium have previously been reported in colitis as well (58, 75), yet this is surprising, as they are more commonly”
BackgroundJitsumura, M., Cunningham, A., Hitchings, M. D., Islam, S., Davies, A. P., Row, P. E., Riddell, A. D., Kinross, J. K., Wilkinson, T. S., Jenkins, G. J. S., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021987 · Cited by 7
The Human Microbiome in Health and Disease
Hill, C. J., Ross, R. P., Stanton, C., & O’Toole, P. W. (2016) · Wiley eBooks · doi:10.1002/9783527682386.ch4 · Cited by 7
Examining miR-196a, miR-196b and NF-κBIα gene expression in colitis mice model
Rafiezadeh, Z., Aboutalebian, S., Baradaran, A., Hoveida, L., & Hejazi, S. H. (2025) · AMB Express · doi:10.1186/s13568-025-01869-7 · Cited by 5
“The symptoms of IBD can be relieved by certain strains of probiotics, particularly those found in the Bifidobacterium and Lactobacillus genera (Wang et al. 2014).”
The role of Lactobacillus in diseases and its intervention by Chinese herbs
Lai, H., Yan, D., Zhang, J., Li, B., & Li, F. R. (2025) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2025.100655 · Cited by 5
Reactivity of Autologous Serum IgG to Gut Microbes in Pediatric Ulcerative Colitis
Tabassum, N., Nakayama‐Imaohji, H., Munyeshyaka, E., Tada, A., Kondo, T., Kondo, S., Kusaka, T., & Kuwahara, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178196 · Cited by 6
Neumann, G., Wall, R., Rangel, I., Marques, T. M., & Repsilber, D. (2018) · BMC Systems Biology · doi:10.1186/s12918-018-0667-6 · Cited by 6
“These transporters are downregulated in patients with IBD [42, 49].”
BackgroundInfluentialJasem, M. K., Fattahnia, F., Mohammadi, Y., Shokri, A., Behroozyar, H. K., & Kazemi‐Bonchenari, M. (2022) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2022.115372 · Cited by 5
Li, X. B., Huang, X., Li, Q., Li, X. Y., Li, J. H., Li, C. L., He, L. J., Jing, H., & Yang, K. L. (2022) · BMC Veterinary Research · doi:10.1186/s12917-022-03510-2 · Cited by 6
“On the one hand, Lactobacillus is a beneficial microorganism promoting the health of the gastrointestinal tract and host by competitively inhibiting infection and colonization by pathogenic bacteria [85].”
BackgroundGut microbiome modulation: Ancillary effects of inorganic nanoparticles on gut microflora
Abbas, S., Uzair, B., Butt, M. A., Menaa, F., & KHAN, B. A. (2022) · Biocell · doi:10.32604/biocell.2023.025311 · Cited by 8
Effects of Starch Overload and Cecal Buffering on Fecal Microbiota of Horses
Bustamante, C. C., de Paula, V. B., Rabelo, I. P., Fernandes, C. C., Kishi, L. T., Canola, P. A., Lemos, E. G. D. M., & Valadão, C. A. A. (2022) · Animals · doi:10.3390/ani12233435 · Cited by 6
“In spite of Lactobacilli and Bifidobacteria generally being considered probiotic and health-promoting [21,44], some studies have reported higher prevalence of these bacteria in patients with gastrointestinal tract disease [45,46].”
D’Amico, V., Siepmann, F., Siepmann, J., Neut, C., Denora, N., & Lopedota, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107670 · Cited by 9
Mady, E. A., El‐Husseiny, H. M., Makioka‐Itaya, Y., Ishikawa, S., Inoüe, R., Li, C., Yamamoto, Y., & Nagaoka, K. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118513 · Cited by 4
Banzragch, M., Sanli, K., Stensvold, C. R., Kurt, Ö., & Arı, Ş. (2023) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2023.2223708 · Cited by 6
Hasan, R., Kumar, A., Bose, S. K., Roy, R., Arora, A., Sharma, P., Nagumantri, S. P., Paul, D., & Choudhury, S. (2023) · The Open Microbiology Journal · doi:10.2174/18742858-v17-e230803-2023-7 · Cited by 4
Carrimycin ameliorates lipopolysaccharide and cecal ligation and puncture-induced sepsis in mice
Lai, J., LIANG, J., Kunsen, C. H. E. N., Guan, B., Linqin, C. H. E. N., Linqin, C. H. E. N., Jiqiang, F. A. N., Zhang, Y., Qiumei, L. I., Su, J., et al. (2024) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(24)60600-x · Cited by 7
Self-citationChen, S., Zhang, D., Li, D., Zeng, F., Chen, C., & Bai, F. (2025) · Medicine · doi:10.1097/md.0000000000041262 · Cited by 4
Rosso, A. D., Aguilera, P., Quesada, S., Mascardi, M. F., Mascuka, S. N., Cimolai, M. C., Cerezo, J., Spiazzi, R. A., Conlon, M. C., Milano, C., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10112190 · Cited by 4
“This is consistent with previous reports that identified Bifidobacterium as an overrepresented genus in active UC patients [64].”
ResultVersalovic, J. A., Highlander, S. K., & Petrosino, J. F. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch15 · Cited by 5
Dynamic Human Gut Microbiome and Immune Shifts During an Immersive Psychosocial Therapeutic ProgramPreprint
Zhou, X., Ganz, A. B., Rayner, A., Cheng, T. Y., Oba, H., Rolnik, B. M., Lancaster, S. M., Lu, X., Li, Y., Johnson, J. S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.26.600881 · Cited by 4
“Our findings on Bifidobacterium also demand attention; while much psychobiome research has focused on Lactobacillus and Bifidobacterium 159,167-169 , our analysis and previous studies suggest Bifidobacterium 's role in psychiatric disorders may be more complex than previously thought 138,170,171 .”
Lisco, G., Tullio, A. D., Zupo, R., Prete, M., Piazzolla, G., Racanelli, V., & Triggiani, V. (2025) · Immunologic Research · doi:10.1007/s12026-025-09655-0 · Cited by 4
“All the authors approved the final version of the paper and approved the manuscript submission.”
Abdelbadiee, S., Yoon, G., Pearman, K., Kumar, A., & Harvey, P. (2025) · Biomedicines · doi:10.3390/biomedicines13122916 · Cited by 4
Mendonça, I. P., da Silva, R. S., de Paiva, I. H. R., Costa, B. L. D. S. A., Teixeira, K. P. D. S. B., de Souza, J. R. B., & Peixoto, C. A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02152-2 · Cited by 6
Dubinkina, V. B., Tyakht, A., Ilina, E. N., Ischenko, D. S., Kovarsky, B. A., Yarygin, K. S., Pavlenko, A. V., Popenko, A., Alexeev, D. G., Taraskina, A. E., et al. (2016) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750816020037 · Cited by 4
Effect of Butyrate on Food-Grade Titanium Dioxide Toxicity in Different Intestinal In Vitro Models
Becht, J. M., Kohlleppel, H., Schins, R. P. F., & Kämpfer, A. A. M. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00086 · Cited by 3
Metadata
- Authors
- Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., Wang, G., & Xia, B.
- Affiliations
- Zhongnan Hospital of Wuhan University (CN)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2014-02
- Volume
- 52
- Issue
- 2
- Pages
- 398-406
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3911339
- OpenAlex
- W2097788076
- Cited by
- 509
- References
- 48
- Citations by year
- 2026: 26 · 2025: 46 · 2024: 47 · 2023: 56 · 2022: 74 · 2021: 56 · 2020: 53 · 2019: 39 · 2018: 29 · 2017: 24 · 2016: 28 · 2015: 12 · 2014: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut dysbiosis, Bifidobacterium, Lactobacillus, Faecalibacterium prausnitzii, butyrate-producing bacteria, mucosa-associated bacteria, fecal bacteria, probiotics, 16S rRNA gene
- MeSH terms
- Adolescent, Adult, Bifidobacterium, Biopsy, Butyrates, Feces, Female, Humans, Intestinal Mucosa, Lactobacillus, Male, Middle Aged, RNA, Bacterial, RNA, Ribosomal, 16S, Inflammatory Bowel Diseases, Gastrointestinal Tract, Young Adult, Biota, Bacterial Load, Real-Time Polymerase Chain Reaction, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.